RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02179 RECBIO-B

Not Yet Opened 04-14 13:04:01

5.100

+0.100

+2.00%

High5.060	Low5.060	Vol4.00K
Open5.060	D1 Closing5.000	Amplitude0.00%
Mkt Cap3.19B	Tradable Cap1.61B	Total Shares626.00M
T/O20.24K	T/O Rate0.00%	Tradable Shares316.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"RECBIO-B","latestPrice":5.1,"timestamp":1776143041413,"preClose":5,"halted":0,"volume":4000,"delay":0,"changeRate":0.019999999999999928,"floatShares":316000000,"shares":626000000,"eps":-1.3226220596413996,"marketStatus":"Not Yet Opened","change":0.1,"latestTime":"04-14 13:04:01","open":5.06,"high":5.06,"low":5.06,"amount":20240,"amplitude":0,"askPrice":5.2,"askSize":5000,"bidPrice":5.1,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.2409645237852784,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776216600000},"marketStatusCode":0,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":5,"openAndCloseTimeList":[[1776130200000,1776139200000],[1776142800000,1776153600000]],"volumeRatio":1.0256410098619333,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"1178549258","title":"RECBIO-B Reports Unchanged Share Structure and Confirms Sufficient Public Float for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1178549258","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178549258?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:49","pubTimestamp":1775036972,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (RECBIO-B) submitted its monthly return to Hong Kong Exchanges and Clearing Limited on 01 April 2026, detailing share movements for the month ended 31 March 2026....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197825380","title":"Stock Track | RECBIO-B Plunges 25% Intraday After Reporting Widening Annual Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1197825380","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197825380?lang=en_us&edition=fundamental","pubTime":"2026-03-25 16:01","pubTimestamp":1774425673,"startTime":"0","endTime":"0","summary":"RECBIO-B's stock price plummeted 25% during intraday trading on Wednesday, following the release of the company's annual financial results for 2025.The biopharmaceutical company reported a loss...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622048359","title":"Jiangsu Recbio Technology's Loss Deepens in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2622048359","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622048359?lang=en_us&edition=fundamental","pubTime":"2026-03-25 09:50","pubTimestamp":1774403400,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology  posted a loss attributable to owners of 610.4 million yuan for 2025, widening from 562.4 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Loss per share came in at 1.15 yuan, compared with 1.16 yuan a year ago.Revenue was 12.7 million yuan, compared with nil revenue reported in 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141359722","title":"RECBIO-B Reports Annual Loss of 610 Million Yuan, Widening 8.54% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1141359722","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141359722?lang=en_us&edition=fundamental","pubTime":"2026-03-25 07:12","pubTimestamp":1774393945,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced its annual results for the period ending December 31, 2025. The company reported revenue of 12.726 million yuan. The loss attributable to shareholders was 610 million yuan,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622019859","title":"Jiangsu Recbio Technology FY Revenue RMB 12.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622019859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622019859?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:14","pubTimestamp":1774390458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nPLX0DE944:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153094557","title":"RECBIO-B Appoints Wei Qifang and Sun Jiaen as Joint Company Secretaries","url":"https://stock-news.laohu8.com/highlight/detail?id=1153094557","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153094557?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:44","pubTimestamp":1774363490,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced that Ms. Weng Meiyi has resigned from her positions as the company's Company Secretary, Authorized Representative under Rule 3.05 of the Listing Rules of The Stock Exchange...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155406531","title":"Recbio Announces Management Reshuffle: New Joint Company Secretaries and Authorised Representative Named","url":"https://stock-news.laohu8.com/highlight/detail?id=1155406531","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155406531?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:41","pubTimestamp":1774363306,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (“Recbio”) disclosed a series of corporate governance adjustments, effective 24 March 2026, aimed at strengthening board administration and compliance with Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095589","title":"Recbio appoints Wei Qifang and Suen Ka Yan as joint company secretaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095589","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621095589?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:39","pubTimestamp":1774363155,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio said Mei Yee Yung resigned as company secretary, authorized representative, and Hong Kong process agent, effective March 24, 2026.Qifang Wei and Ka Yan Suen were appointed joint company secretaries, with Wei also named authorized representative and Suen appointed Hong Kong process agent.Wei joined the group on October 26, 2025 and currently serves as assistant to the chairman and secretary to the board.His prior roles include global risk director at ZTE and managing director of the investment banking division at Guosen Securities.Suen is an assistant manager at SWCS Corporate Services Group  with more than nine years of corporate secretarial experience.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Techno","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL1YQQFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","LU1580142542.USD","BK0018","BK0030","BK0171","BK0276","002736","LU2328871848.SGD","BK0103","BK0183","LU1781817850.SGD","LU1064130708.USD","BK0196","BK0000","BK0026","BK0012","LU1064131003.USD","BK0067","BK0167","BK0123","LU1969619763.USD","000063","02179","BK0148","BK0188","BK0090","LU2148510915.USD","BK1161","BK0058","BK0125","BK0055","LU1328615791.USD","BK0214"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102731298","title":"RECBIO-B (02179) Sets 24 March 2026 Board Meeting to Review FY 2025 Results and Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1102731298","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102731298?lang=en_us&edition=fundamental","pubTime":"2026-03-12 17:42","pubTimestamp":1773308576,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (RECBIO-B, 02179) announced that its board of directors will convene on Tuesday, 24 March 2026. The meeting’s agenda includes: 1. Reviewing and approving the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618180894","title":"Jiangsu Recbio schedules board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2618180894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618180894?lang=en_us&edition=fundamental","pubTime":"2026-03-12 17:36","pubTimestamp":1773308181,"startTime":"0","endTime":"0","summary":"Recbio’s board will meet on March 24, 2026 to consider and approve the group’s annual results for the year ended December 31, 2025. The board will also consider a final dividend at the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDLD3mS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126509803","title":"Jiangsu Recbio (02179) Announces February Monthly Return with No Change in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1126509803","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126509803?lang=en_us&edition=fundamental","pubTime":"2026-03-02 17:38","pubTimestamp":1772444338,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. disclosed its February 2026 monthly return. The total authorized and issued share capital remained unchanged, standing at 626.08 million shares in total—comprising...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610688925","title":"Jiangsu Recbio Gets HKEX Approval for Hong Kong Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610688925","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610688925?lang=en_us&edition=fundamental","pubTime":"2026-02-09 12:31","pubTimestamp":1770611471,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology  said the Hong Kong Stock Exchange has granted listing approval for its Hong Kong share full circulation application, according to a Feb. 6 bourse filing.The approval covers the conversion of about 142 million unlisted shares into Hong Kong-listed shares.The converted shares represent about 22.67% of the company's total issued share capital.Upon completion of the conversion, Jiangsu Recbio's H-shares will increase to about 458.1 million, accounting for roughly 73.17% of total issued shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1226287529.USD","LU0456846285.SGD","LU0762541174.USD","LU0067412154.USD","LU0797268264.HKD","LU2226246903.HKD","IE0003795394.USD","LU0540923850.HKD","LU1242518857.USD","LU0314109678.HKD","LU0501845795.SGD","LU1282649810.SGD","SG9999002562.SGD","LU0320764599.SGD","LU0955623706.USD","LU0955648018.USD","LU0762542818.HKD","LU2039709279.SGD","LU0561508036.HKD","LU0648948544.HKD","LU0359201612.USD","LU0261947096.USD","LU0831093199.SGD","LU1211504680.USD","LU0594300419.USD","02179","LU0072462343.USD","LU0856984785.SGD","LU0791590937.USD","LU1366334651.USD","LU1044875133.USD","LU1044876610.USD","LU0819123356.HKD","00388","LU0359202008.SGD","LU0417516738.SGD","LU0488056044.USD","SG9999002463.SGD","LU1993786604.SGD","IE00BKZH1Z71.USD","LU0197773673.USD","HEXmain","SG9999004220.SGD","LU0572944931.SGD","HKXCY","80388","LU0886674414.USD","IE00B3T34201.USD","LU1813983027.USD","LU1282648689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135343398","title":"Jiangsu Recbio (2179) Announces H Share Full Circulation Listing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1135343398","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135343398?lang=en_us&edition=fundamental","pubTime":"2026-02-06 19:42","pubTimestamp":1770378146,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) announced that it received listing approval from The Stock Exchange of Hong Kong Limited on February 5, 2026 for converting 141,953,489 unlisted...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198911641","title":"RECBIO-B Granted Listing Approval by Stock Exchange for H Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1198911641","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198911641?lang=en_us&edition=fundamental","pubTime":"2026-02-06 19:38","pubTimestamp":1770377907,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) has announced that the company received approval from the Stock Exchange on February 5, 2026, for the listing and trading of 142 million H shares.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108684931","title":"Jiangsu Recbio Technology (02179) Announces January 2026 Monthly Return on Movements in Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1108684931","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108684931?lang=en_us&edition=fundamental","pubTime":"2026-02-02 17:04","pubTimestamp":1770023084,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (02179) reported that, as of January 31, 2026, the total authorized share capital remained at RMB 626,075,702. This comprises 297,937,013 Domestic Shares,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176846253","title":"RECBIO-B Receives CSRC Filing Notice for H-Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1176846253","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176846253?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:04","pubTimestamp":1769994241,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced that the company has recently received a filing notice from the China Securities Regulatory Commission (CSRC) dated January 13, 2026, regarding its H-share full circulation...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163956745","title":"RECBIO-B (02179): China Securities Regulatory Commission Issues Filing Notice for Company's H-Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1163956745","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163956745?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:48","pubTimestamp":1769784495,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced that the company has recently received a filing notice from the China Securities Regulatory Commission (CSRC) dated January 13, 2026, regarding its H-share full circulation...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152580502","title":"Jiangsu Recbio Technology (2179) Receives CSRC Filing Notice for H Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1152580502","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152580502?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:45","pubTimestamp":1769784327,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (Stock Code: 2179) announced that it has obtained a filing notice dated January 13, 2026 from the China Securities Regulatory Commission (CSRC), confirming...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607804195","title":"Jiangsu Recbio Receives CSRC Filing Notice for H Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2607804195","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607804195?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:39","pubTimestamp":1769783990,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. announced that it has received a filing notice dated January 13, 2026, from the China Securities Regulatory Commission  regarding its H Share Full Circulation Plan. The company indicated that the details of the implementation plan, including the conversion and listing of shares, have not yet been finalized and remain subject to additional procedures required by the Stock Exchange of Hong Kong and other regulatory authorities. Jiangsu Recbio stated it will provide further updates as the process progresses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL2SvrfH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602593074","title":"Haoyu Xu Spends CN¥1.7m Buying Jiangsu Recbio Technology Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602593074","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602593074?lang=en_us&edition=fundamental","pubTime":"2026-01-12 08:28","pubTimestamp":1768177719,"startTime":"0","endTime":"0","summary":"Potential Jiangsu Recbio Technology Co., Ltd. ( HKG:2179 ) shareholders may wish to note that insider Haoyu Xu recently...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/haoyu-xu-spends-cn17m-buying-jiangsu-recbio-technology-share","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/haoyu-xu-spends-cn17m-buying-jiangsu-recbio-technology-share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CN","02179","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.2439},{"period":"1month","weight":0.2718},{"period":"3month","weight":-0.1866},{"period":"6month","weight":-0.2388},{"period":"1year","weight":-0.263},{"period":"ytd","weight":0.275}],"compareEarnings":[{"period":"1week","weight":0.0301},{"period":"1month","weight":0.016},{"period":"3month","weight":-0.0418},{"period":"6month","weight":-0.0006},{"period":"1year","weight":0.208},{"period":"ytd","weight":0.0094}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Jiangsu Recbio Technology Co Ltd is a China-based company engaged in vaccine research and development. The Company is still in the research and development stage. The Company's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009257},{"month":2,"riseRate":0.25,"avgChangeRate":-0.058747},{"month":3,"riseRate":0.25,"avgChangeRate":-0.071963},{"month":4,"riseRate":0.4,"avgChangeRate":-0.016858},{"month":5,"riseRate":0.25,"avgChangeRate":-0.027385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.013774},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016314},{"month":8,"riseRate":0.25,"avgChangeRate":-0.033938},{"month":9,"riseRate":0.25,"avgChangeRate":-0.012227},{"month":10,"riseRate":0.5,"avgChangeRate":0.027812},{"month":11,"riseRate":0,"avgChangeRate":-0.140794},{"month":12,"riseRate":0.75,"avgChangeRate":0.059254}],"exchange":"SEHK","name":"RECBIO-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RECBIO-B,02179,RECBIO-B股票,RECBIO-B股票老虎,RECBIO-B股票老虎国际,RECBIO-B行情,RECBIO-B股票行情,RECBIO-B股价,RECBIO-B股市,RECBIO-B股票价格,RECBIO-B股票交易,RECBIO-B股票购买,RECBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}